1114 Serine acetyltransferase N-terminal domain
Ligands and drugs
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
ClassyFire chemical superclasses of the ligands bound by this X-group's proteins, from DrugDomain annotations.
The raw number of superclasses rises with the number of proteins sampled; the per-20 value compares X-groups at equal depth.
| Superclass | Proteins | Expected | 0.25×observed / expected4× | Ratio | Significance |
|---|---|---|---|---|---|
| Homogeneous metal compounds | 2 | 5.3 | 0.38× | q = 0.10 | |
| Organic acids and derivatives | 9 | 1.7 | 5.36× | not tested | |
| Organic oxygen compounds | 2 | 2.2 | 0.93× | not tested | |
| Homogeneous non-metal compounds | 2 | 2.3 | 0.86× | not tested |
Unit: a protein (UniProt accession) with a ligand-binding domain in this X-group, counted once per superclass. Expected counts use each superclass's frequency across all ligand-binding X-groups; significance is Fisher's exact test with Benjamini–Hochberg correction. Buffers and crystallization additives are excluded. ECOD v295.2; the method follows the ECOD 2027 update, whose published figures used a slightly different artifact filter.
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB00151 | CYS | Cysteine | 37 |
| DB00133 | SER | Serine | 4 |
| DB00125 | ARG | Arginine | 3 |
| DB02078 | PG5 | Triglyme | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| CYS | CYSTEINE | 45 |
| MGmetal | MAGNESIUM ION | 13 |
| NAmetal | SODIUM ION | 7 |
| SER | SERINE | 5 |
| LMR | (2S)-2-hydroxybutanedioic acid | 4 |
| ARG | ARGININE | 3 |
| 15P | POLYETHYLENE GLYCOL (N=34) | 2 |
| CL | CHLORIDE ION | 2 |
| PG5 | 1-METHOXY-2-[2-(2-METHOXY-ETHOXY]-ETHANE | 1 |